Kachhela – potency product | Buy in Ukraine with delivery

What is Kachhela?

Kachhela is a complex-action medicinal product belonging to the pharmacological group of agents affecting the respiratory system and the body's immune response. The manufacturer of the drug is the pharmaceutical company Kachhela, which specializes in the development of innovative formulas to support respiratory health. The drug is available in the form of enteric-coated tablets, which ensures the precise release of active components in the appropriate section of the gastrointestinal tract. Thanks to its well-thought-out composition, Kachhela combines anti-inflammatory, mucolytic, and immunomodulatory properties, allowing it to be used both in the acute period of the disease and for the prevention of relapses. The drug is dispensed by prescription, as it requires prior diagnosis and the determination of an individual therapeutic strategy.

The pharmacodynamics of Kachhela is based on the synergistic interaction of several active substances, each of which has proven clinical efficacy. The main vector of action is aimed at reducing the viscosity of bronchial secretions, suppressing excessive inflammatory reaction of the mucous membrane, and stimulating local immunity. Such a multi-component approach allows achieving a stable therapeutic effect in diseases of the upper and lower respiratory tract. Clinical observations confirm that the use of Kachhela helps shorten the duration of cough, facilitate sputum expectoration, and reduce the frequency of complications. The drug is well tolerated by patients of various age groups; however, it requires strict adherence to the recommended dosage regimen.

A special feature of Kachhela is the use of a phased active ingredient release technology, which ensures a uniform concentration of active components in blood plasma for twelve hours. This allows taking the drug twice a day without loss of therapeutic efficacy. The manufacturer of Kachhela pays significant attention to quality control at all stages of production — from the synthesis of substances to final packaging. Each batch of the drug undergoes multi-stage verification for compliance with pharmacopoeial standards. Thanks to this, Kachhela has established itself as a reliable agent in the complex therapy of bronchopulmonary diseases.

What is Kachhela prescribed for?

Kachhela is prescribed for acute and chronic bronchitis accompanied by difficult expectoration of thick sputum and paroxysmal cough. In such cases, the active components of the product help thin bronchial secretions, reduce irritation of cough receptors, and facilitate the evacuation of mucus from the respiratory tract. The therapeutic effect is usually observed already on the second or third day of regular intake, which is confirmed by a decrease in the frequency and intensity of coughing fits. It is important to understand that Kachhela does not suppress the cough reflex, but normalizes its physiological function, converting a dry, non-productive cough into a moist and productive one.

The next important indication is tracheitis and laryngotracheitis of viral or bacterial etiology, when the inflammatory process involves the mucous membrane of the trachea and larynx. Kachhela reduces tissue edema, decreases respiratory tract hyperreactivity, and promotes the restoration of epithelial integrity. Thanks to the immunomodulatory component, the drug activates local defense mechanisms, which is especially relevant during the season of increased incidence of respiratory infections. Patients note a decrease in tickling and sore throat sensations, as well as an improvement in overall well-being.

Kachhela is also used as part of complex therapy for chronic obstructive pulmonary disease and bronchial asthma in order to improve bronchial drainage function. In such clinical situations, the drug helps reduce the frequency of exacerbations, decrease the need for short-acting bronchodilators, and improve the quality of life of patients. Additionally, Kachhela can be recommended during the convalescence period after pneumonia to accelerate the recovery of lung tissue. The prescription of the drug must always be based on the results of a clinical examination and take into account the individual characteristics of the disease course.

Composition and active components of Kachhela

The basis of the drug Kachhela is a combination of three active pharmaceutical substances, each performing a clearly defined therapeutic function. The first component is acetylcysteine, a classic direct-acting mucolytic that cleaves disulfide bonds in the mucopolysaccharide molecules of sputum. This leads to the depolymerization of mucus, reducing its viscosity and facilitating its elimination from the respiratory tract. Acetylcysteine also possesses pronounced antioxidant activity, protecting mucous membrane cells from damage by free radicals formed during the inflammatory process. Additionally, this substance promotes the synthesis of glutathione — a key endogenous antioxidant that supports liver detoxification function.

The second active component of Kachhela is marshmallow root extract, standardized for polysaccharide content. This herbal substance forms a protective film on the surface of the respiratory tract mucous membrane, reducing irritation and promoting epithelial regeneration. Marshmallow polysaccharides have demulcent properties, thereby reducing the sensitivity of cough receptors and decreasing the frequency of reflex coughing fits. Marshmallow extract also stimulates the secretion of the liquid fraction of bronchial mucus, which further facilitates sputum expectoration. Importantly, this component is well tolerated even during prolonged use and is non-addictive.

The third component is bromelain, a proteolytic enzyme obtained from pineapple stems, which has systemic anti-inflammatory and anti-edematous action. Bromelain modulates the synthesis of pro-inflammatory cytokines, reduces vascular wall permeability, and promotes the resorption of inflammatory infiltrates. As part of Kachhela, bromelain potentiates the action of acetylcysteine, improving the penetration of the mucolytic into the deep parts of the bronchial tree. Excipients of the drug include microcrystalline cellulose, corn starch, magnesium stearate, and an enteric coating based on hydroxypropyl methylcellulose. These substances ensure shape stability, dosing accuracy, and protection of active substances from premature destruction in the stomach.

Dosage of Kachhela

The standard therapeutic dose of Kachhela for adult patients and adolescents aged fourteen and over is one tablet twice daily. The tablet should be taken morning and evening, preferably at the same time, to maintain a stable concentration of active substances in the blood plasma. The maximum daily dose should not exceed two tablets, as exceeding the recommended amount does not lead to an increased therapeutic effect, but increases the risk of side effects. The duration of the treatment course is determined by the doctor individually depending on the nature and severity of the disease, but usually ranges from seven to fourteen days.

In chronic respiratory diseases, Kachhela may be prescribed according to a maintenance regimen: one tablet once daily for a long period — from one to three months. Such a regimen allows reducing the frequency of exacerbations and maintaining normal bronchial drainage function. Patients with impaired renal or hepatic function may require a dose adjustment carried out by a physician based on creatinine clearance and transaminase levels. Elderly patients usually do not require special dose adjustment; however, it is recommended to start treatment with the minimum effective dose and carefully monitor drug tolerance.

For children aged six to fourteen years, Kachhela is prescribed in a reduced dose — half a tablet twice daily; however, this dosage form is not always convenient for accurate dosing in pediatric practice. Therefore, for younger children, the manufacturer recommends using alternative dosage forms of mucolytic agents after consulting a pediatrician. If a patient missed a regular dose of Kachhela, they should not double the next dose to make up for the missed one. It is necessary to continue taking it according to the usual schedule, maintaining an interval between doses of at least eight hours.

How to take Kachhela correctly?

Kachhela tablets should be taken after meals, swallowed with a sufficient amount of room temperature water — at least 150–200 milliliters. Taking it after meals reduces the risk of gastric mucosal irritation and ensures a more even absorption of active components. The tablet must not be chewed, crushed, or dissolved in water, as the enteric coating protects the active substances from destruction by gastric hydrochloric acid. Violation of the coating's integrity leads to a decrease in the drug's bioavailability and may cause irritation of the gastric mucosa. To achieve an optimal therapeutic effect, it is recommended to observe equal intervals between doses — approximately twelve hours.

During treatment with Kachhela, it is important to ensure adequate fluid intake — at least one and a half to two liters of fluid per day. Sufficient body hydration enhances the mucolytic action of the drug, contributing to the thinning of sputum and facilitating its removal. It is recommended to consume warm drinks, herbal teas, fruit drinks, and still water, avoiding excessively hot or cold liquids that can irritate the respiratory tract mucous membrane. If a patient forgets to take Kachhela at the appointed time, they should take the tablet as soon as they remember, provided that at least four hours remain until the next dose. Otherwise, the missed dose should be skipped and treatment continued according to the regular schedule.

During therapy with Kachhela, simultaneous use of centrally acting antitussive agents that suppress the cough reflex should be avoided. Combining a mucolytic with antitussives can lead to the accumulation of thinned sputum in the respiratory tract and the development of congestion. If the need for combination therapy arises, the doctor may prescribe an antitussive agent only at night, and Kachhela during the daytime. Patients with diabetes mellitus should take into account that the tablet coating may contain small amounts of sucrose, so blood glucose levels should be monitored during treatment. In the absence of improvement within five to seven days of therapy, it is necessary to re-consult a doctor to review the diagnosis and adjust the treatment tactics.

Side effects of Kachhela

The most common adverse reactions when using Kachhela are dyspeptic disorders, which occur in approximately five to seven percent of patients. These include nausea, a feeling of heaviness in the epigastric region, reduced appetite, and rarely, vomiting. These symptoms are usually mild to moderate, occur at the beginning of therapy, and disappear on their own within a few days without the need to discontinue the drug. To reduce the severity of dyspeptic symptoms, it is recommended to take the tablets after meals and drink a sufficient amount of water. In rare cases, diarrhea or constipation may develop, which is associated with individual sensitivity to the components of the drug.

On the part of the immune system, allergic reactions are possible, manifesting as skin rash, itching, urticaria, or skin redness. The frequency of such reactions does not exceed one percent; however, patients prone to allergies should be especially careful during the first doses of Kachhela. Extremely rarely, angioedema, bronchospasm, or anaphylactic reactions may occur, requiring immediate discontinuation of the drug and seeking emergency medical attention. Neurological side effects include headache, dizziness, and increased fatigue, which usually resolve after the body adapts to the drug during the first three to four days of treatment.

In patients with a history of gastric or duodenal ulcer disease, Kachhela may trigger an exacerbation of the underlying disease, manifested by increased epigastric pain, heartburn, and dyspepsia. In such patients, the drug is prescribed with caution and under medical supervision, often in combination with proton pump inhibitors. Any unusual reaction of the body that occurs while taking Kachhela and is not mentioned in the instructions requires consultation with a doctor to assess its connection with the drug. It must be remembered that the individual reaction of the body to the medication may differ from that described in typical clinical cases, so the patient's well-being is a key criterion for safety of therapy.

Contraindications of Kachhela

Absolute contraindications to the use of Kachhela are hypersensitivity to any component of the drug, including active substances and excipients. Patients with a history of allergic reactions to acetylcysteine, bromelain, or plants of the Malvaceae family are not prescribed the drug due to the high risk of cross-allergic reactions. Gastric and duodenal ulcer disease in the acute phase is also an absolute contraindication, as mucolytic components can damage the protective mucous barrier. Children under six years of age are considered a contraindication due to the lack of sufficient data on the safety and efficacy of Kachhela in this age group.

Relative contraindications include pregnancy and lactation, as controlled clinical studies involving pregnant women have not been conducted. Prescription of Kachhela to pregnant women is possible only when the expected benefit to the mother outweighs the potential risk to the fetus, and strictly under medical supervision. In patients with bronchial asthma, the drug should be used with caution, as bromelain can cause bronchospasm in susceptible individuals. Severe hepatic impairment and renal failure with a creatinine clearance of less than thirty milliliters per minute require dose adjustment or the selection of alternative treatment.

Patients with phenylketonuria should consider the possible content of aspartame in the tablet coating if such a sweetener is used in the excipients. In elderly patients, Kachhela is prescribed with caution due to an increased risk of gastrointestinal side effects. Before starting therapy, the doctor must carefully collect an anamnesis, paying attention to concomitant diseases, allergic status, and medications that the patient is taking constantly. Self-medication with Kachhela without prior consultation with a doctor is strictly not recommended, as improper use can mask symptoms of serious respiratory diseases.

Interaction of Kachhela with other drugs and alcohol

Kachhela can interact with a number of drugs, so before starting therapy, it is necessary to inform the doctor about all medications that the patient takes constantly or episodically. Concomitant use of Kachhela with centrally acting antitussives, such as codeine or dextromethorphan, can lead to dangerous accumulation of thinned sputum in the respiratory tract. Acetylcysteine reduces the absorption of certain antibiotics, in particular tetracyclines, ampicillin, and amphotericin B, so the interval between taking these drugs and Kachhela should be at least two hours. Nitroglycerin and other nitrates, when used concurrently with acetylcysteine, may enhance the vasodilatory effect, requiring blood pressure monitoring.

Consumption of alcohol during treatment with Kachhela is not recommended, as ethanol enhances the irritant effect of the drug on the gastric mucosa and increases the risk of dyspeptic disorders. In addition, alcohol can reduce the effectiveness of the drug's immunomodulatory component and slow down the regeneration of the respiratory tract mucous membrane. Patients who drive vehicles or operate complex machinery should take into account that Kachhela can cause dizziness and reduced concentration, especially at the beginning of therapy. If such symptoms appear, it is necessary to refrain from driving until the condition stabilizes.

Where to buy Kachhela in Ukraine

You can purchase Kachhela in pharmacy chains of Ukraine upon presentation of a prescription from a doctor, as the product belongs to the prescription group of medicines. The availability of the drug in different regions of the country may vary depending on the established distribution channels of the manufacturer Kachhela. It is recommended to check the availability of the drug in a specific pharmacy in advance by phone or via online medicine booking services. Many pharmacy chains offer a pre-order service, which guarantees receiving the drug at a convenient time.

Kachhela must be stored in its original packaging at a temperature not exceeding twenty-five degrees Celsius, in a place protected from light and inaccessible to children. The shelf life of the drug is three years from the date of manufacture, after which the use of the product is strictly prohibited. Some online pharmacies offer delivery of Kachhela by courier or postal services; however, upon receipt, it is necessary to check the integrity of the packaging and the compliance of the drug series with the ordered one. Before using Kachhela, be sure to consult a doctor, as only a qualified specialist can evaluate the appropriateness of prescribing the drug taking into account the individual characteristics of the body and the nature of the disease.